Company MedPacto, Inc.

Equities

A235980

KR7235980000

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Annual profits - Rate of surprise

Sector Bio Therapeutic Drugs

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-09 EDT			5-day change	1st Jan Change
9,010 ^KRW	-1.21%		-3.53%	+24.45%

2023	MedPacto, Inc. announced that it has received KRW 10.85806127 billion in funding from Theragen Etex Co.,Ltd.	CI
2023	South Korean Shares Nearly Unchanged Ahead of US Inflation Data	MT

MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as the treatment of multiple myeloma, lung cancer, stomach cancer, colon cancer, blood cancer, triple negative breast cancer and pancreatic cancer, among others.

Managers	Title	Age	Since
Seong-Jin Kim FOU	Founder	70	-
Seon-Jeong Kim DFI	Director of Finance/CFO	56	-
Gi-Baek Ham CTO	Chief Tech/Sci/R&D Officer	65	-
Jeong-Im Heo BRD	Director/Board Member	53	-
Byung-Ho Lee AUD	Comptroller/Controller/Auditor	68	-

Members of the board	Title	Age	Since
Seong-Jin Kim FOU	Founder	70	-
Jeong-Im Heo BRD	Director/Board Member	53	-
Young-Shik Kim BRD	Director/Board Member	62	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	33,580,695	24,132,586 ( 71.86 %)	0	71.86 %
Stock B	0	82,146	0	0

Name	Equities	%	Valuation
THERAGEN ETEX CO.,LTD. 14.68 %	4,931,039	14.68 %	48 M ₩
Seong-Jin Kim 6.401 %	2,149,334	6.401 %	21 M ₩
Jin-Up Go 3.573 %	1,200,000	3.573 %	12 M ₩
National Pension Service of Korea 3.020 %	1,014,055	3.020 %	10 M ₩
Young-won Kim 0.9675 %	324,910	0.9675 %	3 M ₩
Sae-rom Kim 0.3176 %	106,668	0.3176 %	1 M ₩
Yip-sae Kim 0.1191 %	40,000	0.1191 %	389 229 ₩
Tae-gon Lim 0.1191 %	40,000	0.1191 %	389 229 ₩
Seon-Jeong Kim 0.0969 %	32,550	0.0969 %	316 735 ₩
MedPacto, Inc. ESOA 0.0300 %	10,062	0.0300 %	97 911 ₩

MedPacto, Inc.

Borim Building 92 Myeongdal-ro

06668, Seoul

http://www.medpacto.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
MEDPACTO, INC.	+24.45%	221M
VERTEX PHARMACEUTICALS INCORPORATED	+3.91%	109B
REGENERON PHARMACEUTICALS, INC.	+10.87%	105B
ARGENX SE	+1.28%	22.25B
BIONTECH SE	-13.14%	22.09B
GENMAB A/S	-7.05%	18.68B
WUXI APPTEC CO., LTD.	-38.36%	17.58B
BEIGENE, LTD.	-10.66%	16.85B
NEUROCRINE BIOSCIENCES, INC.	+3.75%	13.76B
SAREPTA THERAPEUTICS, INC.	+36.70%	12.46B

Bio Therapeutic Drugs